or Try an Advanced Search...

    Severe Plaque Psoriasis Stocks List

    Symbol Grade Name % Change
    ABBV B AbbVie Inc. -0.67
    BIIB C Biogen Idec Inc. -0.02
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major
    Related Stock Lists: Immunosuppressants Psoriasis S&P 500 Adalimumab Advanced Prostate Cancer Alzheimer's Disease Anemia Atopic Dermatitis Autoimmune Disease Autoimmune Disorders Biotechnology Blood Cancers Cd20 Chronic Idiopathic Constipation Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Combination Drugs Constipation Crohn's Disease

    Related ETFs - A few ETFs which own one or more of the above listed Severe Plaque Psoriasis stocks.

    Symbol Grade Name Weight
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 10.68
    MEDI C Harbor Health Care ETF 10.38
    BOTZ C Global X Robotics & Artificial Intelligence Thematic ETF 10.01
    PJP A PowerShares Dynamic Pharmaceuticals 9.87
    HDLB B ETRACS Monthly Pay 2xLeveraged US High Dividend Low Volatility ETN Series B due September 30, 2044 9.8
    View all Severe Plaque Psoriasis ETFs...
    Compare ETFs
    Compare FTXH to HDLB Compare FTXH to MEDI Compare PJP to HDLB

        Severe Plaque Psoriasis Stocks Recent News

        Date Stock Title
        Jul 1 ABBV 2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
        Jul 1 ABBV AbbVie (ABBV) Gets CHMP Nod for Lymphoma Drug's Expanded Use
        Jul 1 ABBV AbbVie names Robert A. Michael to CEO role
        Jul 1 ABBV Robert A. Michael Assumes Role as AbbVie Chief Executive Officer
        Jul 1 ABBV 3 Magnificent Stocks Retirees Can Buy and Hold Forever
        Jul 1 BIIB 10 clinical trials to watch in the second half of 2024
        Jul 1 ABBV 10 clinical trials to watch in the second half of 2024
        Jun 29 ABBV How Do These 3 Healthcare Dividend Stocks Deliver Reliable Income And Growth?
        Jun 28 ABBV How Medicare drug price negotiations could hit pharma stocks
        Jun 28 ABBV Coherus offloads Humira biosimilar Yusimry for $40m
        Jun 28 ABBV AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
        Jun 28 ABBV AbbVie, Genmab blood cancer therapy endorsed in EU
        Jun 28 ABBV Pharma Stock Roundup: FDA's CRL to MRK & ABBV, Phase III Study Failures for NVO, AZN
        Jun 28 ABBV AbbVie's (ABBV) Celsius Therapeutics Deal to Boost IBD Presence
        Jun 28 BIIB Biogen, Eisai launch Alzheimer's drug Leqembi in China
        Jun 28 BIIB Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
        Jun 28 ABBV AbbVie completes acquisition of Celsius Therapeutics for $250m
        Jun 28 ABBV AbbVie Receives Positive CHMP Opinion for Epcoritamab (TEPKINLY®) for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
        Jun 28 BIIB Eisai and Biogen launch Alzheimer's drug Leqembi in China
        Jun 27 BIIB “LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
        Related Industries: Drug Manufacturers - Major
        Related Stock Lists: Immunosuppressants Psoriasis S&P 500 Adalimumab Advanced Prostate Cancer Alzheimer's Disease Anemia Atopic Dermatitis Autoimmune Disease Autoimmune Disorders Biotechnology Blood Cancers Cd20 Chronic Idiopathic Constipation Chronic Lymphocytic Leukemia Clinical Trial Product Clinical Trial Products Combination Drugs Constipation Crohn's Disease
        Severe Plaque Psoriasis

        Browse All Tags